COMPASS Pathways Plc (CMPS) — Fluence, a leading provider of professional education in psychedelic therapy, today announced that it has been selected by Compass Pathways plc (Nasdaq: CMPS) as a recipient of its U.S. healthcare provider training grant program. Through the collaboration, Fluence is developing a new certificate program designed to prepare healthcare providers to deliver high-quality care for patients receiving COMP360 psilocybin treatment, if approved by the U.S. Food and Drug Administration (FDA).
Source: PR Newswire — read the full announcement there.
See our COMPASS Pathways company profile for background, links, and more COMPASS Pathways news.